Forte Biosciences, Inc. · NASDAQ:FBRX

Orbimed Advisors LLC reported a 8.00% stake in Forte Biosciences, Inc. (Schedule 13G)

Event Dec 31, 2024 · Filed Feb 14, 2025

Orbimed Advisors LLC reported a 8.00% stake in Forte Biosciences, Inc., 510,000 shares, as a passive investor on Dec 31, 2024. Filed Feb 14, 2025 (Schedule 13G).

Stake
8.00%
Shares
510,000
Intent
Passive
What changed
Crossed above 5%
Filed together
2 holders

The filing in full

HolderStakeShares
ORBIMED ADVISORS LLC8.00%510,000
ORBIMED CAPITAL LLC1.40%90,000

Source

View original at SEC

Related